2020/11/17 16:13:43

Jiao Hong, director of the State Food and drug administration, and his delegation visited Watson for guidance

At 9:00 a.m. on November 8, Jiao Hong, director of the State Food and drug administration, Mo Zongtong, director of Jiangsu food and drug administration, Ding Chun, mayor of Changzhou, Dai Wenlong, director of Changzhou food and drug administration, and Zhang Xiaohu, deputy director of Wujin District, and other provincial, municipal and district leaders visited Changzhou Huasen Medical Equipment Co., Ltd. for inspection and guidance. Hu Renmin, chairman of the company, Hu Xiaowen, executive president, Zhou Jin, general manager and leaders of all departments warmly received the visiting leaders.

In the conference room of the company, Hu Renmin, chairman of the board of directors, first welcomed the presence of all leaders. Zhou Jin, general manager, introduced the basic situation of Watson to the visiting leaders, and focused on the medical 3D printer project and the sternum plate products (acceptance No.: xter 2014-070) that entered the special approval channel for national innovative products.

Then, accompanied by Hu Xiaowen, CEO of the company, leaders visited the 3D printing R & D department and showed strong interest in the application of 3D printing in orthopedic field.

Watson has always attached great importance to the development of innovative products, and all new product development is based on cooperation with clinicians. In recent years, we have launched a large batch of patent and utility model patent products, including core drilling intramedullary nail system, ankle internal fixation system, sternum plate, pure titanium rib plate, three row nail stapler, sled type endoscopic stapler, orthopedic 3D printer, etc., which has been fully recognized by clinical doctors. Deputy director Jiao Hong had a detailed understanding of our new product R & D and encouraged our company to continue to promote the R & D and application of new products and technologies to better meet clinical needs.

Watson will continue to carry forward the advantages of scientific research and innovation, and make high-quality products with the attitude of continuous improvement, so as to better contribute to the health and safety cause of our country.